TMEM81 Inhibitors
TMEM81 Inhibitors are chemically diverse entities that exert their inhibitory effects on the functional activity of TMEM81 through indirect interactions with various cellular signaling cascades and regulatory mechanisms. Inhibitors such as Wortmannin and LY 294002 target the phosphatidylinositol 3-kinase (PI3K) pathway, leading to a dampened AKT signaling cascade. This reduction in PI3K/AKT signaling can indirectly affect TMEM81's function as this pathway plays a crucial role in a multitude of cellular processes, including growth and survival, where TMEM81 could potentially be involved. Furthermore, Rapamycin, by inhibiting the mammalian target of rapamycin (mTOR) pathway, may influence the trafficking and turnover of TMEM81, which could lead to its diminished membrane stability or localization, indirectly reducing its activity.
Additional inhibitors operate through different mechanisms but result in comparable outcomes for TMEM81 function. Cyclopamine, by hindering Smoothened in the Hedgehog signaling pathway, can affect the endosomal sorting and trafficking that are essential for the proper localization and function of TMEM81. U0126 and PD 98059, both targeting the MAPK signaling pathway via MEK inhibition, and SB 203580, a p38 MAPK inhibitor, can modulate cellular stress responses and differentiation processes that indirectly involve TMEM81. By disrupting the cytoskeletal dynamics and cell motility through ROCK kinase inhibition, Y-27632 may alter the activity of TMEM81. And Bafilomycin A1, through its action on V-ATPase, could affect the endolysosomal trafficking of TMEM81. These inhibitors, by targeting various kinases and signaling molecules, contribute to a multifaceted regulatory environment where TMEM81's activity is indirectly modulated through changes in cellular signaling, trafficking, and regulatory processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent phosphoinositide 3-kinase (PI3K) inhibitor. By inhibiting PI3K, it diminishes the PI3K/AKT signaling pathway, which can lead to a reduction in the functional activity of TMEM81 as this pathway is critical for various cellular processes including proliferation and survival that may indirectly involve TMEM81. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, which leads to the downregulation of the mTOR pathway. Since mTOR signaling can influence membrane protein trafficking and degradation processes, the inhibition of this pathway could lead to decreased functional activity of TMEM81 by altering its membrane localization or stability. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
Cyclopamine is an inhibitor of the Hedgehog signaling pathway, specifically targeting Smoothened. As Hedgehog signaling can regulate endosomal sorting and trafficking, the inhibition of this pathway could indirectly decrease the functional activity of TMEM81 through altered intracellular trafficking. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is another PI3K inhibitor. It blocks the PI3K/AKT pathway, leading to diminished AKT activation and subsequent effects on downstream processes such as cell survival, which could indirectly affect the functional activity of TMEM81. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream regulators of the ERK/MAPK pathway. By preventing the activation of this pathway, U0126 could indirectly decrease the functional activity of TMEM81 by impacting processes such as cell differentiation or proliferation that may involve TMEM81. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 specifically inhibits p38 MAPK, which is involved in cellular stress responses. The inhibition of p38 MAPK might lead to alterations in cellular responses to stress and thereby indirectly affect the functional activity of TMEM81. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a specific inhibitor of the vacuolar-type H+-ATPase (V-ATPase). By blocking V-ATPase, it disrupts endosomal acidification and lysosomal function, which might indirectly decrease the functional activity of TMEM81 by influencing its endolysosomal trafficking. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of ROCK kinases. Inhibition of ROCK can lead to changes in cytoskeletal dynamics and cell motility, which may indirectly influence the functional activity of TMEM81 by affecting its cellular distribution or membrane association. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a specific inhibitor of MEK, which is part of the ERK/MAPK signaling cascade. By inhibiting MEK, PD 98059 can indirectly decrease the functional activity of TMEM81 by affecting cellular processes that are potentially regulated by TMEM81. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a small-molecule inhibitor of the GTPase activity of dynamin, which is involved in clathrin-mediated endocytosis. The inhibition of dynamin can lead to reduced endocytosis, which might affect the functional activity of TMEM81 if it is internalized or recycled via this route. | ||||||